Cost-effectiveness analysis of a communication-focused therapy for pre-school children with autism: results from a randomised controlled trial

BackgroundAutism is associated with impairments that have life-time consequences for diagnosed individuals and a substantial impact on families. There is growing interest in early interventions for children with autism, yet despite the substantial economic burden, there is little evidence of the cost-effectiveness of such interventions with which to support resource allocation decisions. This study reports an economic evaluation of a parent-mediated, communication-focused therapy carried out within the Pre-School Autism Communication Trial (PACT).Methods152 pre-school children with autism were randomly assigned to treatment as usual (TAU) or PACT + TAU. Primary outcome was severity of autism symptoms at 13-month follow-up. Economic data included health, education and social services, childcare, parental productivity losses and informal care.ResultsClinically meaningful symptom improvement was evident for 53 % of PACT + TAU versus 41 % of TAU (odds ratio 1.91, p = 0.074). Service costs were significantly higher for PACT + TAU (mean difference £4,489, p < 0.001), but the difference in societal costs was smaller and non-significant (mean difference £1,385, p = 0.788) due to lower informal care rates for PACT + TAU.ConclusionsImprovements in outcome generated by PACT come at a cost. Although this cost is lower when burden on parents is included, the cost and effectiveness results presented do not support the cost-effectiveness of PACT + TAU compared to TAU alone.Trial registrationCurrent Controlled Trials ISRCTN58133827

[1]  P. Coyte,et al.  The cost-effectiveness of expanding intensive behavioural intervention to all autistic children in Ontario: in the past year, several court cases have been brought against provincial governments to increase funding for Intensive Behavioural Intervention (IBI). This economic evaluation examines the c , 2006, Healthcare policy = Politiques de sante.

[2]  S. Bradley-Johnson.  Mullen Scales of Early Learning , 1997 .

[3]  Martin Knapp,et al.  Measuring the Parental, Service and Cost Impacts of Children with Autistic Spectrum Disorder: A Pilot Study , 2003, Journal of autism and developmental disorders.

[4]  Gina Green,et al.  Cost–benefit estimates for early intensive behavioral intervention for young children with autism—general model and single state case , 1998 .

[5]  G. Bonsel,et al.  Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study , 2010, Quality of Life Research.

[6]  Marc A. Koopmanschap,et al.  Economic valuation of informal care , 2004, The European Journal of Health Economics, formerly: HEPAC.

[7]  Sarah Byford,et al.  Service and Wider Societal Costs of Very Young Children with Autism in the UK , 2012, Journal of autism and developmental disorders.

[8]  Martin Knapp,et al.  Economic cost of autism in the UK , 2009, Autism : the international journal of research and practice.

[9]  M. Koopmanschap,et al.  Economic valuation of informal care. An overview of methods and applications. , 2004, The European journal of health economics : HEPAC : health economics in prevention and care.

[10]  Jamie Zibulsky,et al.  Vineland Adaptive Behavior Scales, Second Edition , 2014 .

[11]  Hubert Korzilius,et al.  Cost comparison of early intensive behavioral intervention and treatment as usual for children with autism spectrum disorder in The Netherlands. , 2012, Research in developmental disabilities.

[12]  J Raftery,et al.  Costing in economic evaluation , 2000, BMJ : British Medical Journal.

[13]  M. Rutter,et al.  Adult outcome for children with autism. , 2004, Journal of child psychology and psychiatry, and allied disciplines.

[14]  M J Al,et al.  Costs, effects and C/E-ratios alongside a clinical trial. , 1994, Health economics.

[15]  S. Rogers,et al.  Evidence-Based Comprehensive Treatments for Early Autism , 2008, Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53.

[16]  K Claxton,et al.  The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. , 1999, Journal of health economics.

[17]  J. C. Cabasés Hita.  [Economic evaluation of health care]. , 1987, Revista de enfermeria.

[18]  S G Thompson,et al.  Analysis and interpretation of cost data in randomised controlled trials: review of published studies , 1998, BMJ.

[19]  Jonathan Green,et al.  A new social communication intervention for children with autism: pilot randomised controlled treatment study suggesting effectiveness. , 2004, Journal of child psychology and psychiatry, and allied disciplines.

[20]  D McDaid,et al.  Estimating the costs of informal care for people with Alzheimer's disease: methodological and practical challenges , 2001, International journal of geriatric psychiatry.

[21]  Nalin Payakachat,et al.  Autism spectrum disorders: a review of measures for clinical, health services and cost–effectiveness applications , 2012, Expert review of pharmacoeconomics & outcomes research.

[22]  Tony Charman,et al.  Parent-mediated communication-focused treatment in children with autism (PACT): a randomised controlled trial , 2010, The Lancet.

[23]  Elisabeth Fenwick,et al.  A guide to cost-effectiveness acceptability curves. , 2005, The British journal of psychiatry : the journal of mental science.

[24]  I. Goodyer,et al.  Cost-effectiveness of selective serotonin reuptake inhibitors and routine specialist care with and without cognitive–behavioural therapy in adolescents with major depression , 2007, British Journal of Psychiatry.

[25]  B. Leventhal,et al.  The Autism Diagnostic Observation Schedule—Generic: A Standard Measure of Social and Communication Deficits Associated with the Spectrum of Autism , 2000, Journal of autism and developmental disorders.

[26]  G. Chasson,et al.  Cost Comparison of Early Intensive Behavioral Intervention and Special Education for Children with Autism , 2007 .

[27]  G. Loomes,et al.  The use of QALYs in health care decision making. , 1989, Social science & medicine.

[28]  M. Koopmanschap,et al.  A Practical Guide for Calculating Indirect Costs of Disease , 1996, PharmacoEconomics.

[29]  C. Kenning,et al.  Mental health provision for young offenders: service use and cost , 2006, British Journal of Psychiatry.

[30]  M. Knapp,et al.  Costs of autism spectrum disorders in the United Kingdom and the United States. , 2014, JAMA pediatrics.

[31]  John Mullahy,et al.  Net Health Benefits: A New Framework for the Analysis of Uncertainty in Cost-Effectiveness Analysis , 1998 .

[32]  A. Couteur,et al.  Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders , 1994, Journal of autism and developmental disorders.

[33]  J. Barber,et al.  Factors that influence the cost of caring for patients with severe psychotic illness , 2001, British Journal of Psychiatry.

[34]  Katherine Stevens,et al.  Assessing the performance of a new generic measure of health-related quality of life for children and refining it for use in health state valuation , 2011, Applied health economics and health policy.

[35]  J Hjelmgren,et al.  Health economic guidelines--similarities, differences and some implications. , 2001, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[36]  M. Kenward,et al.  An Introduction to the Bootstrap , 2007 .

[37]  Tristram H. Smith,et al.  Challenges in Evaluating Psychosocial Interventions for Autistic Spectrum Disorders , 2005, Journal of autism and developmental disorders.

[38]  M. Sculpher,et al.  Representing uncertainty: the role of cost-effectiveness acceptability curves. , 2001, Health economics.

[39]  M. Knapp,et al.  Annotation: Economic evaluations of child and adolescent mental health interventions: a systematic review. , 2005, Journal of child psychology and psychiatry, and allied disciplines.